Precision Optics Corporation, Inc.
$4.44
▲
6.48%
2026-04-21 08:54:01
www.poci.com
NCM: POCI
Explore Precision Optics Corporation, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$47.43 M
Current Price
$4.44
52W High / Low
$6.04 / $3.55
Stock P/E
—
Book Value
$1.21
Dividend Yield
—
ROCE
-40.7%
ROE
-73.56%
Face Value
—
EPS
$-0.93
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
90
Beta
0.33
Debt / Equity
47.33
Current Ratio
1.05
Quick Ratio
1.06
Forward P/E
—
Price / Sales
1.87
Enterprise Value
$35.73 M
EV / EBITDA
-5.52
EV / Revenue
1.46
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 2. | Bausch + Lomb Corporation | $16.76 | — | $5.94 B | — | 1.55% | -5.39% | $18.91 / $10.45 | $18.2 |
| 3. | Pro-Dex, Inc. | $53.3 | 15.38 | $174.44 M | — | 22.96% | 30.87% | $70.26 / $23.47 | $12.97 |
| 4. | Anbio Biotechnology | $26.98 | 380.56 | $3.88 B | — | 11.61% | 27.05% | $55.65 / $6.05 | $0.63 |
| 5. | Milestone Scientific Inc. | $0.29 | — | $23.33 M | — | -155% | -1.32% | $1.11 / $0.22 | $0.04 |
| 6. | Repligen Corporation | $130.14 | 150.55 | $7.4 B | — | 1.48% | 2.4% | $175.77 / $109.66 | $37.39 |
| 7. | Becton, Dickinson and Company | $155.63 | 25.5 | $44.7 B | 2.65% | 6.35% | 6.96% | $187.35 / $127.54 | $88.79 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.37 M | 6.68 M | 6.18 M | 4.19 M | 4.53 M | — |
| Operating Profit | -1.74 M | -1.6 M | -1.36 M | -2.04 M | -0.91 M | — |
| Net Profit | -1.78 M | -1.64 M | -1.4 M | -2.1 M | -0.97 M | — |
| EPS in Rs | -0.16 | -0.15 | -0.13 | -0.19 | -0.09 | -0.21 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 19.09 M | 19.1 M | 21.04 M | 15.68 M |
| Operating Profit | -5.55 M | -2.72 M | -0.64 M | -1.35 M |
| Net Profit | -5.78 M | -2.95 M | -0.14 M | -0.93 M |
| EPS in Rs | -0.53 | -0.27 | -0.01 | -0.08 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 19.79 M | 16.91 M | 19.74 M | 16.7 M |
| Total Liabilities | 7.53 M | 6.84 M | 7.69 M | 7.73 M |
| Equity | 12.26 M | 10.07 M | 12.05 M | 8.97 M |
| Current Assets | 10.06 M | 7.12 M | 9.86 M | 6.51 M |
| Current Liabilities | 6.15 M | 4.91 M | 5.26 M | 4.59 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -3.55 M | -2.68 M | -0.08 M | -0.93 M |
| Investing CF | -0.23 M | -0.29 M | -0.05 M | -0.41 M |
| Financing CF | 5.15 M | 0.46 M | 2.45 M | 1.09 M |
| Free CF | -3.78 M | -2.98 M | -0.13 M | -1.09 M |
| Capex | -0.23 M | -0.29 M | -0.05 M | -0.15 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -9.22% | 34.23% | — | — |
| Earnings Growth % | -1940.88% | 84.42% | — | — |
| Profit Margin % | -15.45% | -0.69% | -5.92% | — |
| Operating Margin % | -14.26% | -3.03% | -8.62% | — |
| Gross Margin % | 30.35% | 36.75% | 31.43% | — |
| EBITDA Margin % | -13.15% | 1.36% | -3.71% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-11-02 | 1:0.333333 |